Bio-Techne FY26 net earnings more than doubled to $240.68 million; net sales slip 0.38% to $1.22 billion - TECH News | RalliesBio-Techne FY26 net earnings more than doubled to $240.68 million; net sales slip 0.38% to $1.22 billion
T
TECH• Fiscal 2026 results
- Bio-Techne fiscal 2026 net earnings climbed to $240.68 million, while net sales were flat at $1.22 billion.
- GAAP gross margin widened 1 percentage point to 65.8%.
- Non-GAAP adjusted net earnings edged down 1% to $303.34 million, while adjusted gross margin narrowed 0.8 percentage point to 69.6%.
Merger agreement with Merck KGaA
- An agreement was signed on June 25 to merge with Merck KGaA; shareholders would receive $73 per share in cash at closing.
- The deal is expected to close in late 2026 or early 2027, subject to shareholder approval and regulatory clearances.
EWY
•
